Allen A. Cognitive-behavior therapy and other psychosocial interventions in the treatment of obsessive compulsive disorder. Psychiatric Annals, 2006, 36(7): 474-479. Psychiatric Annuals, 2006, 36(7): 474-479.
http://www.psychiatricannalsonline.com/view.asp?rID=20730

Allen A., Hollander E. Diagnosis and treatment of obsessive-compulsive disorder. Primary Psychiatry, 2005, 12: 34-42.
http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=234

Sussman, N. Interview of Andrea Allen: Profiles in Psychiatry: In session with Andrea Allen PhD: Cognitive behavioral therapy for obsessive-compulsive disorder. Primary Psychiatry, 2008, 15: 39-42.
http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=1625

Allen A., Pallanti S. The family in the treatment of obsessive-compulsive disorder. In Hudak, Robert; and Dougherty, Darin. Clinical Obsessive-Compulsive Disorders in Adults and Children. Cambridge University Press, 2011, pp 172-183. Cambridge Books Online. Cambridge University Press. 03 July 2011
http://dx.doi.org/10.1017/CBO9780511973796.013

Allen A., Dell'Osso B., Fochtmann L.J., McIntyre J. SCME Course for: Practice Guideline for the Treatment of Patients with Obsessive-Compulsive Disorder. American Psychiatric Association, 2007.

Dell'Osso B., Nestadt G., Allen A., Hollander E. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. Journal of Clinical Psychiatry, 2006, 67(4): 600-610.

Dell'Osso B., Altamura A.C., Allen A., Hollander, E. (2005) Brain stimulation techniques in the treatment of obsessive- compulsive disorder: current and future directions. CNS Spectrums, Dec; 10(12):966-79, 983.

Dell'Osso, B., Allen A., Hollander, E. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Expert Opinion on Pharmacotherapy, 2005, Dec; 6(15):2727-40.

Hollander E., Allen A., Steiner M., Wheadon D.E., Oakes R., Burnham D. Acute and long-term treatment and prevention of relapse of obsessive compulsive disorder with paroxetine. Journal of Clinical Psychiatry, 2003, 61:1113-1121.

Hollander E., Friedberg J., Wasserman S., Allen A., Birnbaum M., Koran L.M. Venlafaxine in treatment-resistant obsessive-compulsive disorder. Journal of Clinical Psychiatry, 2003, 64:546-550.

Allen A., King A.F., Hollander E. Obsessive-compulsive spectrum. Dialogues in Clinical Neuroscience, 2003, 5(3):259-271.

Hollander E. & Allen A. Serotonergic drugs and the treatment of disorders related to obsessive-compulsive disorder. In: Pato MT & Zohar J (eds.) Current Treatments of Obsessive-Compulsive Disorder, 2^nd Edition., Washington, DC, American Psychiatric Publishing, Inc. 2001.

Stein, D.J., Allen A., Bobes J., Eisen J.L., Figuera M.L., Iikura Y., Koran L.M., Hollander E. Quality of life in Obsessive-Compulsive disorder. CNS Spectrums, 2000, 5(6, suppl 4): 37-39.

Hollander, E. & Allen A. Quality of Life in OCD. Abstracts for the 4th International Obsessive-Compulsive Disorder Conference, February 10-12, 2000. St Thomas.

Hollander, E., Kaplan A., Allen A., Cartwright C. Pharmacotherapy for obsessive-compulsive disorder. Psychiatric Clinics of North America, 2000. 23:643-656.

Hollander, E. & Allen A., Editors. Obsessive-Compulsive Spectrum Disorders. Psychiatric Clinics of North America, 2000, 23.

Allen A., Hollander E., Steiner M., Wheadon D.E., Bushnell W., Gergel I.P. Long-term treatment and prevention of relapse obsessive-compulsive disorder with paroxetine. Scientific Abstracts of the 38th Annual Meeting of the American College of Neuropsychopharmacology, 1999.

Aronowitz B.R., DeCaria C.M., Allen A., Margolin L., Simon L., Saunders A., Weiss N., Reimoser G.E., Mosovich S., Hollander E. Neuropsychological findings in Autism, Asperger's Disorder, Obsessive-Compulsive Disorder and controls. Abstracts of the American Psychiatric Association 150th Annual Meeting, May 22, 1997. San Diego, California.